What is Nebula Genomics?
Nebula Genomics specializes in advanced DNA testing, offering a comprehensive 30x Whole Genome Sequencing service that empowers individuals to decode their entire genetic makeup. Established in 2018, the company provides products aimed at consumers keen on understanding their health predispositions, ancestral origins, and genomic data. A core tenet of Nebula Genomics' operation is a robust commitment to privacy and data security, ensuring users maintain control over their sensitive information.
The company extends its services to business clients seeking to leverage personalized genetic insights for lifestyle enhancements, including tailored recommendations for diet, exercise, and overall well-being. Operating across multiple locations, Nebula Genomics is dedicated to democratizing access to personal genomics and contributing to the broader field of genomic research within the business services and R&D sectors.
How much funding has Nebula Genomics raised?
Nebula Genomics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Nebula Genomics
PPP
Public-Private Partnership
What's next for Nebula Genomics?
With substantial backing and a clear strategic direction, Nebula Genomics is well-positioned to further innovate its whole genome sequencing technology and expand its market reach. The company's focus on privacy and data security is a critical differentiator in the consumer genomics landscape, likely to attract a growing user base. Future growth may involve strategic partnerships to enhance data analysis capabilities or expand research collaborations, further solidifying its role in personalized health and wellness. The company's late-stage funding context suggests a trajectory towards broader commercialization and potentially new service offerings that leverage the power of comprehensive genomic data.
See full Nebula Genomics company page
